UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Degnan Chris
UroGen Pharma Ltd | 3: Initial statement of beneficial ownership of securities-Officer Degnan Chris
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Smith Jason Drew
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Kim Dong
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Wildman Daniel George
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Holden Stuart
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Robinson James A. Jr.
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director WEN LEANA
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director BUTITTA CYNTHIA M
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cowen Financial Products LLC(4.36%),Cowen and Company, LLC(1.21%)
UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(6.2%),Point72 Capital Advisors, Inc.(6.2%), etc.
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.6%)
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark
UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Arkin Communications Ltd.(4.44%),Moshe Arkin(4.44%)
UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
No Data
No Data